長期服用丙戊酸鈉致 2 型糖尿病一例及分析_Journal of Epilepsy

Authors：

魏才 , 胡曉霞 , 郝茹 , 王易娟 , 勇彤 , 努爾比亞 ,  楊俊

Corresponding?author：

楊俊, Email: junyang0919@163.com

Keywords：

DOI：

10.7507/2096-0247.20180087

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Citation： 魏才, 胡曉霞, 郝茹, 王易娟, 勇彤, 努爾比亞,楊俊. 長期服用丙戊酸鈉致 2 型糖尿病一例及分析. Journal of Epilepsy, 2018, 4(6): 558-559. doi: 10.7507/2096-0247.20180087 Copy

1.	Aly RH, Amr NH, Saad WE, et al. Insulin resistance inpatients on valproic acid: relation to adiponectin. Acta Neurol Scand, 2015, 131(3): 169-175.
2.	丁美萍, 包穎穎, 陳忠. 丙戊酸鈉治療與胰島素抵抗. 浙江大學學報醫學版, 2004, 33(3): 216-218.
3.	Najafi MR, Bazooyar B, Zare M, et al. The investigation of insulin resistance in two groups of epileptic patients treated with sodium valproate and carbamazepine. Adv Biomed Res, 2017, 6: 25.
4.	Rakitin A, Eglit T, Koks S, et al. Comparison of the metabolic syndrome risk in valproate-treated patients with epilepsy and the general population in Estonia. PLoS One, 2014, 9(7): e103856.
5.	Rakitin A. Doesvalproic acid have potential in the treatment of diabetes mellitus? Front Endocrinol (Lausanne), 2017, 8: 147.
6.	Martin CK, Han H, Anton SD, et al. Effect of valproic acid on body weight, food intake, physical activity and hormones: results of a randomized controlled trial. J Psychopharmacol, 2009, 23(7): 814-825.
7.	Ye J. Improving insulin sensitivity with HDAC inhibitor. Diabetes, 2013, 62(3): 685-687.

1. Aly RH, Amr NH, Saad WE, et al. Insulin resistance inpatients on valproic acid: relation to adiponectin. Acta Neurol Scand, 2015, 131(3): 169-175.
2. 丁美萍, 包穎穎, 陳忠. 丙戊酸鈉治療與胰島素抵抗. 浙江大學學報醫學版, 2004, 33(3): 216-218.
3. Najafi MR, Bazooyar B, Zare M, et al. The investigation of insulin resistance in two groups of epileptic patients treated with sodium valproate and carbamazepine. Adv Biomed Res, 2017, 6: 25.
4. Rakitin A, Eglit T, Koks S, et al. Comparison of the metabolic syndrome risk in valproate-treated patients with epilepsy and the general population in Estonia. PLoS One, 2014, 9(7): e103856.
5. Rakitin A. Doesvalproic acid have potential in the treatment of diabetes mellitus? Front Endocrinol (Lausanne), 2017, 8: 147.
6. Martin CK, Han H, Anton SD, et al. Effect of valproic acid on body weight, food intake, physical activity and hormones: results of a randomized controlled trial. J Psychopharmacol, 2009, 23(7): 814-825.
7. Ye J. Improving insulin sensitivity with HDAC inhibitor. Diabetes, 2013, 62(3): 685-687.